ArticleBlood cell therapy2026

Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients.

Shigeo Fuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.